Glps company information, Employees & Contact Information

Many people using GLP-1 weight loss drugs may not be eating enough nutritious food UCHealth

Osteoarthritis treatment via the GLP-1–mediated gut-joint axis targets intestinal FXR signaling Science | AAAS

Serena Williams’s GLP-1s partnership marks a disturbing cultural turning point The Independent

Mapping the effectiveness and risks of GLP-1 receptor agonists Nature

Texas sues, accusing Eli Lilly of 'bribing' physicians to prescribe GLP-1s Houston Chronicle

TikTok is flooded with ‘GLP-1 patches,’ despite its ban on selling weight-loss products Fast Company

2 Companies Poised to Capitalize on the Rise of GLP-1 Weight Loss Drugs | Morningstar UK Morningstar Canada

GPs unable to prescribe GLP-1s to patients who need to reduce BMI for lifesaving surgery Pulse Today

Exclusive data: GLP-1’s impact on UK food and drink consumption The Grocer

Our medical expert reveals which GLP-1 supplements REALLY work Daily Mail

Criminals selling fake ‘DIY’ GLP-1 kits with syringe and powder separated Pharmacy Magazine

Which of the breakthrough weight loss medicines can you get in SA? spotlightnsp.co.za

Research shows GLP-1 receptor agonist drugs are effective but come with complex concerns UChicago Medicine

Women on “skinny jabs” must use effective contraception, MHRA urges in latest guidance GOV.UK

Spending on GLP-1s has grown dramatically. Here are the details. American Medical Association

Can GLP-1 medications impact substance use? Penn Medicine

What to eat to mimic the effects of Ozempic, without the jabs The Independent

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment The New England Journal of Medicine

GLP-1 drugs shouldn’t panic food & drink just yet The Grocer

GLP-1 weight-loss drugs may cut risk of dementia and other conditions Pulse Today

Beyond Ozempic: The GLP-1 boom mcpress.mayoclinic.org

How Much of Employers’ Annual Claims Do GLP-1 Drugs Account For? SHRM

GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects Frontiers

Do GLP-1 Supplements Work? Making Sense of Diabetes

A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings Nature

The Government Crackdown on Off-Brand Ozempic Has Begun. Here’s What That Means for You. Men's Health

Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers Hims Investor Relations

Use of GLP-1 Receptor Agonists to Treat Substance and Alcohol Use Disorders is Promising, but Premature UNC Health

Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function Frontiers

Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs CNBC

If GLP-1 Drugs Are Good For Everything, Should We All Be on Them? derekthompson.org

Serena Williams Lost 31 Pounds With GLP-1 Drug: EXCLUSIVE TODAY.com

The 11 Best Sites to Buy GLP-1 Weight Loss Medications Online, Reviewed by Experts in 2025 Everyday Health

Serena Williams Opens Up About Losing Weight On A GLP-1 In An Exclusive Interview: 'It's Not A Shortcut' Women's Health

GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes American Heart Association Journals

Eli Lilly says GLP-1 pill for diabetes and weight loss effective in study, plans to seek FDA approval CBS News

Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database Frontiers

Most GLP-1 Medications Correlated with a Lower Likelihood of Anxiety and Depression Diagnoses Epic Research

Hims & Hers Selling GLP-1 Injection That's Not FDA Approved, From Shady Supplier — And Won’t Make You Talk to a Doctor to Get It Hunterbrook

Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages CNBC

News | Ares to buy industrial giant GLP’s international business excluding China for $3.7 billion CoStar

Novo Nordisk strikes $2 billion deal with a Chinese company making a GLP-1 drug MarketWatch

Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence Frontiers

The truth about ‘natural GLP-1' weight-loss supplements – what doctors want you to know Women's Health

Abu Dhabi Investment Authority Commits USD1.5 Billion to GLP’s New Economy Push 一财全球Yicai Global

ADIA to Invest Up to $1.5B in GLP as Ming Mei Continues to Cash Up Mingtiandi

MHRA finds evidence does not support a link between Glucagon-Like Peptide-1 (GLP-1) receptor agonists and suicidal and self-injurious thoughts and actions GOV.UK

The role of glucagon-like peptide 1 (GLP-1) in addictive disorders British Pharmacological Society | Journals

Ares Management Buying GLP’s Non-China Fund Business for $3.7B Mingtiandi

Weight-loss jab patients to face stricter checks in crackdown on pharmacies BBC

Obesity: Unemployed could get weight loss jabs to return to work BBC

Modulation of Cardiac Ventricular Excitability by GLP-1 (Glucagon-Like Peptide-1) American Heart Association Journals

GLP’s cancelled bond sale trains spotlight on long-term finances The Business Times

Third generation Lapierre Overvolt GLP III e-MTB announced mbr.co.uk